Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.
UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. uniQure will seek FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback